<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03376165</url>
  </required_header>
  <id_info>
    <org_study_id>CB2015_75</org_study_id>
    <secondary_id>2017-A00852-51</secondary_id>
    <nct_id>NCT03376165</nct_id>
  </id_info>
  <brief_title>Post-Operative Myocardial Incident &amp; Atrial Fibrillation</brief_title>
  <acronym>POMI-AF</acronym>
  <official_title>Longitudinal Study of Patients Undergoing Cardiac Surgery or Implantation of a Percutaneous Valve Prosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore predictors of major cardio-vascular events after cardiac surgery and
      trans-catheter valve implantation with a specific interest in studying mechanisms linking
      pre-operative leukocyte, fat and myocardial phenotypes with post-intervention outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2018</start_date>
  <completion_date type="Anticipated">January 2028</completion_date>
  <primary_completion_date type="Anticipated">January 2028</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>major cardio-vascular events after cardiac intervention (surgery or transcatheter valve implantation)</measure>
    <time_frame>from the day of intervention to 10 years</time_frame>
    <description>cardiovascular death, hospitalisation for heart failure, stroke, myocardial infarction, re-intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>peri-operative myocardial injury</measure>
    <time_frame>3 days following intervention</time_frame>
    <description>Area Under the Curve of blood troponin release during the 3 days following cardiac intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative myocardial infarction (type 5 myocardial infarction)</measure>
    <time_frame>10 days following intervention</time_frame>
    <description>myocardial infarction during the peri-operative time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative atrial fibrillation</measure>
    <time_frame>10 days following intervention</time_frame>
    <description>atrial fibrillation onset during post-op hospitalisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>major cardio-vascular events after cardiac intervention (surgery or transcatheter valve implantation)</measure>
    <time_frame>from the day of intervention to 1 year</time_frame>
    <description>cardiovascular death, hospitalisation for heart failure, stroke, myocardial infarction, re-intervention</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Valve Heart Disease</condition>
  <condition>Coronary Artery Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      for all patients, blood samples with isolation of peripheral blood mononuclear cells,
      subcutaneous fat

      for patients undergoing cardiac surgery right atrial and left ventricle myocardial samples;
      Epicardial and mediastinal fat
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients schedulled for cardiac surgery (coronary artery bypass graft surgery
        and/or valvular surgery) or transcatheter valve implantation and referred to the University
        Hospital of Lille with inclusion criteria and no exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled for cardiac surgery (coronary artery bypass graft surgery and/or
             valvular surgery) or transcatheter valve implantation

        Exclusion Criteria:

          -  pregnant woman

          -  urgent surgery or intervention

          -  not able to consent to the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Montaigne, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Montaigne, Prof.</last_name>
    <phone>320445230</phone>
    <phone_ext>+33</phone_ext>
    <email>david.montaigne@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>HÃ´pital Cardiologie, CHU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David Montaigne, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2017</study_first_submitted>
  <study_first_submitted_qc>December 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 18, 2017</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prognosis</keyword>
  <keyword>translational research</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

